Prot# PDX-007: A Phase 1 Open-Label Study of (RS)-10-Propargyl-10-Deazaaminopterin (PDX) with Vitamin B12 and Folic Acid Supplementation in Patients with Previously-Treated Advanced Non-Small Cell Lung Cancer